AI assistant
ARDELYX, INC. — Director's Dealing 2022
Jun 24, 2022
32003_dirs_2022-06-23_5c3e9b9d-dcc0-4990-8d3a-baf662d8cef4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2022-06-15
Reporting Person: Williams Laura A (Chief Medical Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 243717 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $5.19 | 2030-11-02 | Common Stock (105000) | Direct | |
| Stock Option (Right to Buy) | $0.99 | 2032-01-06 | Common Stock (192000) | Direct |
Footnotes
F1: Includes 49,582 Restricted stock units.
F2: Twenty Five Percent (25%) of the shares subject to the option vest on November 2, 2021 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
F3: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.